HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosis

A.S. Ramcharan, K.J. van Stralen, J.D. Snoep, A.K. Mantel-Teeuwisse, Catharina Jacoba Maria Doggen

    Research output: Contribution to journalArticleAcademicpeer-review

    81 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosis'. Together they form a unique fingerprint.